Supramarginal resections for gliomas and brain metastases (Neuro-oncology Morning Session)
Tracks
Strauss 1
| Wednesday, October 8, 2025 |
| 7:00 AM - 8:00 AM |
Speakers & Chairs
Darko Oreskovic
Chair
Prof. David Netuka
Chair Of The Department Of Neurosurgery And Neuro-oncology
Military University Hospital Prague
Chair
Dr Philipp Karschnia
Neurosurgeon
University Hospital of the Friedrich-Alexander-University Erlangen-Nuremberg
Development and validation of a novel prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: a report by the RANO resect group
Dr Nico Teske
Neurosurgical Resident
Uniklinikum Erlangen, Friedrich-alexander-universität Erlangen-nürnberg
Patient age is related to favorable association of supramaximal resection with outcome in glioblastoma – a report of the RANO resect group
Dr Lina-Elisabeth Qasem
Resident
Goethe University
The HiResGlio Trial: Safety and effectiveness of cellular-guided supramaximal resection in glioma surgery – preliminary results
Dr Hao Duan
Neurosurgeon
Sun Yat-sen University Cancer Center
Dynamic changes in molecular profiles and immune microenvironment beyond the margin of glioblastoma underline supramarginal en bloc resection in non-eloquent areas
Dr Kseniia Chizhova
Neurosurgeon
Almazov National Medical Research Centre
Resect More, Live Better? Balancing RANO Criteria and Quality of Life in Glioblastoma Surgery
Dr Tommaso Araceli
Resident
University Hospital Regensburg
Impact of neurosurgical supramarginal resection in brain metastasis
Dr Lina-Elisabeth Qasem
Resident
Goethe University
The HiResMet Trial: Safety and effectiveness of cellular-guided supramaximal resection in surgery for brain metastases – preliminary results
Dr Lina-Elisabeth Qasem
Resident
Goethe University
Prospective investigation of cellular-guided supramaximal resection of brain metastases (HiResMet Trial) and effects of preoperative radiation on the perimetastatic niche
